Portfolio of Coronavirus Treatment and Vaccine Stocks

The following table includes 19 coronavirus treatment and vaccine stocks. For more information about these stocks see These 19 companies are working on coronavirus treatments or vaccines — here’s where things stand.

19 Coronavirus Treatment and Vaccine Stocks



Recent Prices

Emergent BioSolutionsEBS
Gilead SciencesGILD
Inovio PharmaceuticalsINO
Johnson & JohnsonJNJ
Mesoblast LimitedMESO
Regeneron PharmaceuticalsREGN
Roche HoldingRHHBY
Takeda Pharmaceutical Company Ltd.TAK
Translate BioTBIO
Vir BiotechnologyVIR
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Coronavirus Treatment and Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 13 stocks included in the portfolio computations are: AZN, CYDY, EBS, GILD, GSK, INO, JNJ, NVAX, PFE, REGN, RHHBY, SNY and TAK. The current value of the portfolio assumes that $769.23 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 6 stocks excluded from the portfolio computations because of insufficient price data are: BNTX, MESO, MRNA, TBIO, VXRT and VIR.

The current value of a $10,000 investment is $15,091. The percent return is 50.91%. The annualized return is 8.58%.

See Portfolio of Coronavirus Stocks.

See Portfolio of Coronavirus Lockdown Stocks.

See Portfolio of Coronavirus Vaccine Stocks

Related Portfolios

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Telemedicine Stocks

Portfolio of Vaccine Stocks